DIRS.INFO The most relevant business & tech news

☆ Cramer's week ahead: Fed rate decision, earnings from Darden and Cracker Barrel
▼ + stars: | 2024-09-13 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

CNBC's Jim Cramer on Friday guided investors through next week's top Wall Street action, highlighting a long-awaited interest rate decision from the Federal Reserve and earnings from restaurant chain companies Darden and Cracker Barrel. Investors are broadly expecting the central bank to issue a rate cut but are unsure whether it will be by 25 or 50 basis points. Cramer said he's betting on the former, saying he thinks the Fed should be measured when making cuts and not risk an inflation flareup. He added that he thinks the stock is a bargain, but cautioned that Wall Street tends to sell stocks from that sector when the Fed cuts rates. On Thursday, Olive Garden-parent Darden , Cracker Barrel and FedEx are set to report.

Persons: CNBC's Jim Cramer, Cramer, There's, he'll, Mills, Olive Organizations: Federal Reserve, Darden, Fed, Commerce Department, FedEx

The Centers for Disease Control and Prevention said Thursday it has yet to identify “a clear source” of infection in a Missouri patient who tested positive for the bird flu virus despite no known contact with poultry or dairy cows. Since March, there have been 13 bird flu infections in poultry and dairy workers amid an outbreak of H5N1 spreading rapidly in dairy cows across 200 dairy herds in 14 states, according to the CDC. The patient was hospitalized, officials believe, not because of the infection but because of the patient’s underlying medical conditions. They’re also asking about the type and source of meat and dairy the patient consumed, including any raw dairy. No bird flu infections in dairy cattle have been reported in Missouri, state health officials said in a release Friday.

Persons: Nirav Shah, wasn’t, They’re, Shah, ” Shah, Demetre Daskalakis, ” Organizations: Disease Control, Prevention, CDC, ”, CDC’s National Center Locations: Missouri

Here's a rapid-fire update on all 32 stocks in Jim Cramer's Charitable Trust, the portfolio we use for the CNBC Investing Club. AMD shares have caught a bid in recent days, but they're still cheap considering the growth of its AI processors. Broadcom : Investors who don't own any Broadcom yet should consider starting a position here, Jim said. Although it's tempting to offload shares, Jim said to stick with Honeywell for now because there's huge value in individual businesses like aerospace. There's little negative to say about this portfolio stock.

Persons: Jim Cramer's, Jim, Apple, haven't, it's, that's, he'll, Bob Iger, Bob Chapek, Larry Ellison, Biogen, Eli Lilly, Lowe's, Vimal Kapur, We'd, Linde, Lilly, Morgan Stanley, Goldman Sachs, It's, Jensen Huang, Kamala Harris, Republican Donald Trump, CrowdStrike, Palo, — we're, we're, Brian Niccol, Sands, Stanley Black, Decker, Wells, Charlie Scharf's, Jim Cramer, Angela Weiss Organizations: Jim Cramer's Charitable Trust, CNBC, Club, Abbott Laboratories, Abbott Labs, AMD, Amazon, Web, Broadcom, VMWare, Federal Reserve, Costco Wholesale, Coterra, DuPont, New York Times, Oracle, GE Healthcare, GE, Honeywell, Linde, Microsoft, Nvidia, Republican, Palo Alto Networks, Palo, Procter & Gamble, Procter, Gamble, Constellation Brands, Modelo, Stanley, TJX, Marshalls, Jim Cramer's Charitable, Traders, New York Stock Exchange, AFP, Getty Locations: Nvidia's, San Francisco, China, Dover, United States, industrials, OpenAI, Palo Alto, Wells Fargo

☆ The current market is 'directionless,' one CIO says, naming 6 stocks he likes right now
▼ + stars: | 2024-09-12 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +4 min

Defensive and dividend plays Alexander's strategy in playing the market right now is through defensive sectors and dividend players. As for dividend plays, Alexander is bullish on the utilities and telco sectors amid falling Treasury yields . Big pharma plays Alexander is also likes health-care and biotech players, especially big pharmaceutical companies producing products serving medical needs. Names he likes include AbbVie , AstraZeneca , Novartis and Johnson & Johnson . Johnson & Johnson, meanwhile, has been building out a "pipeline of drugs," Alexander added.

Persons: Ted Alexander, we've, we're, Alexander, it's, bullish, Durex, They've, Mead Johnson, Johnson Organizations: U.S, U.S . Federal, Sydney, Telecommunications, AT, Verizon, Frontier Communications, London Stock Exchange, Big pharma, AstraZeneca, Novartis, Johnson Locations: U.S ., South Dallas, U.S

☆ Moderna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027
▼ + stars: | 2024-09-12 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its Covid business. The company aims to trim R&D spending to a range of $3.6 billion to $3.8 billion in 2027, down from an expected $4.8 billion at the end of this year, according to a release. Moderna also has five non-respiratory products across cancer, latent viruses and rare diseases that could be approved by 2027, according to the company's release. The company expects 2025 revenue to come in at $2.5 billion to $3.5 billion. From 2026 to 2028, Moderna expects a compounded annual growth rate of more than 25% as new products launch.

Persons: Moderna, Stephane Bancel, Leerink, Mani Foroohar, Foroohar, Michael Yee, Bancel Organizations: Moderna, CNBC, Jefferies Locations: New York, U.S

After eight years of threatening to repeal the Affordable Care Act, more commonly known as Obamacare, former President Donald Trump still doesn’t have a comprehensive plan to replace it. People in the U.S. pay roughly twice as much for health care than any other nation on earth. But is it feasible to create a new health care law that reduces the escalating costs? “Right now, Obamacare is the status quo in health care,” said Larry Levitt, executive vice president of health policy at KFF, a nonprofit group that researches health policy issues. Harris has committed to extending the subsidies; Trump has remained silent.

Persons: Donald Trump, ”, John A . Graves, “, Kamala Harris, Trump, ” Trump, —, Larry Levitt, ” Levitt, Graves, Gerard Anderson, ” Graves, Jill Horwitz, David Sanders, “ We’ve, we’ve, ” Horwitz, Horwitz, Harris, Levitt, “ Trump, that’s Organizations: Trump, Vanderbilt University School of Medicine, U.S . Department of, Treasury, Congressional, “ Republicans, ACA, Republicans, Republican, Committee, House Republicans, Johns Hopkins University Bloomberg School of Public Health, Budget, Affordable, Law, Medicine, UCLA School of Law Locations: United States

☆ Stocks making the biggest moves midday: GameStop, Viking Therapeutics, Trump Media and more
▼ + stars: | 2024-09-11 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +2 min

Trump Media & Technology — The stock fell more than 13% following Tuesday's debate between majority shareholder former President Donald Trump and Democratic Vice President Kamala Harris. Novartis — U.S.-listed shares of the Swiss pharma company slipped nearly 2% on the heels of Bank of America's downgrade to hold from buy. Crypto stocks — Crypto stocks were dragged downward after the price of bitcoin fell slightly overnight, as crypto traders considered central bank policy in Japan . Morgan Stanley — The bank stock lost 1% following a downgrade at Goldman Sachs to neutral from buy. Solar stocks — Solar stocks rose as a group after Vice President Kamala Harris's performance at Tuesday's debate raised confidence in a Democratic victory at the U.S. presidential election.

Persons: Donald Trump, Kamala Harris, Rentokil, it's, bitcoin, Morgan Stanley, Goldman Sachs, Goldman, Morgan, Warren Buffett's Berkshire Hathaway, Kamala Harris's, — CNBC's Sean Conlon, Michelle Fox, Alex Harring, Yun Li, Sarah Min, Samantha Subin Organizations: Trump Media & Technology, Democratic, Trump Media, Nasdaq, GameStop, Novartis — U.S, Swiss pharma, of, Therapeutics, JPMorgan, Viking Therapeutics, Goldman, Bank of America, U.S, Clean Energy, SolarEdge Technology, Sunnova Energy Locations: North America, Japan

☆ Stocks making the biggest moves premarket: Trump Media, GameStop, Dave & Buster's and more
▼ + stars: | 2024-09-11 | by ( Sean Conlon | ) www.cnbc.com time to read: +2 min

Trump Media & Technology – Shares slid more than 11% in the wake of the debate between Republican nominee Donald Trump and Democratic Vice President Kamala Harris . Dave & Buster's – The entertainment stock popped more than 13% after topping earnings estimates for the recent quarter by 15 cents a share. GameStop – The video game retailer's shares plunged more than 10% in premarket trading after the company reported a steep decline in sales. GameStop also announced an "at-the-market" stock offering of up to 20 million shares. Morgan Stanley – Shares of the major bank were down more than 1% after Goldman Sachs downgraded the stock to neutral from buy.

Persons: Donald Trump, Kamala Harris, Rentokil, Rollins, Dave, Buster's, Jefferies, Stocks, Coinbase, MicroStrategy, MARA, Morgan Stanley –, Goldman Sachs, Goldman, Morgan Stanley, —, Alex Harring, Samantha Subin, Jesse Pound, Yun Li, Sarah Min, Tanaya Macheel, Michelle Fox Organizations: Trump Media & Technology, Republican, Democratic, Trump Media, GameStop, Williams, Sonoma, Jefferies, Novartis – U.S, Bank of America, Novartis, Viking Therapeutics, JPMorgan, MARA Holdings Locations: North America, Swiss, Japan

The rate of weight loss with the experimental pill, called amycretin, appears to be more rapid than what’s seen for other drugs. “It’s roughly double the weight loss rate seen with current GLP-1 agonists and approaching procedural or surgical-level outcomes,” said Dr. Christopher McGowan, a gastroenterologist who runs a weight loss clinic in North Carolina. McGowan said that while the weight loss was significant, he still has concerns about how fast people lost weight. “While losing weight is seemingly the end goal, how that weight is lost matters,” he said. Spratt said she would like to know how much of the weight loss came from fat compared with muscle.

Persons: “, ”, Christopher McGowan, ” Dr, Susan Spratt, Spratt, haven’t, Martin Lange, Lange, McGowan, ” McGowan Organizations: Novo Nordisk, European Association for, Diabetes, Population Health Management, Duke Health Locations: Novo, Spain, North Carolina, semaglutide, Wegovy, It’s

The findings bring the phenomenon — and the controversy — of the latest new and powerful weight loss drugs to the youngest age group yet. The new trial looked at liraglutide, the active ingredient used in two of Novo Nordisk’s older GLP-1 drugs: Saxenda, a weight loss drug, and Victoza, a diabetes drug. So instead of looking at overall weight loss like in adult studies, they decided to focus more on BMI, which takes into account both weight and height. A spokesperson for Novo Nordisk said that it has submitted an application to the Food and Drug Administration to expand the approval of liraglutide for weight loss in children ages 6 to 11. Is 6 too young for a weight loss drug?

Persons: Roy Kim, “, ” Kim, Claudia Fox, Fox, Eli Lilly, ”, liraglutide, ” Fox, Sarah Armstrong, ” Armstrong, comorbidities, it’s, ” Wegovy, Zepbound, Shauna Levy, ” Levy Organizations: New England, of Medicine, Novo Nordisk, Cleveland Clinic, Centers for Disease Control, University of Minnesota, BMI, Food and Drug Administration, American Academy of Pediatrics, Duke University, Tulane Bariatric Center Locations: liraglutide, Ozempic, Ohio, U.S, New Orleans

☆ Chocolate, but without the guilt? Why lab-grown cocoa and fermented fava beans could be the future
▼ + stars: | 2024-09-10 | by ( Jacopo Prisco | ) edition.cnn.com time to read: +9 min

One way to tackle these problems is to make chocolate without using cocoa beans — the fermented seed of the cacao tree. It also makes cocoa powder and cocoa butter substitutes. “Instead of cocoa beans, we use fava beans sourced from farms across the UK and Europe, and then we ferment them in a similar way that cocoa farmers ferment their cocoa beans,” said Ross Newton, CEO of Nukoko, a UK-based startup that aims to launch on its domestic market next year. A study published this year shows it’s possible to make chocolate using only the cocoa pod, by replacing traditional sugar with a cocoa gel. “You make chocolate using only components from the fruit and not conventional crystallized sugar from sugar beets.

Persons: we’ve, ”, Max Marquart, shea, We’re, ” Marquart, Sara, Ross Newton, Newton, Michal Beressi Golomb, we’re, “ We’ve, “ That’s, Beressi Golomb, “ We’re, Beressi, “, “ We’d, Kim Mishra, ” Mishra Organizations: CNN, Planet, Department of Health Sciences, Technology, Swiss Institute of Technology Locations: West Africa, Ghana, Ivory Coast, Africa, Brazil, Swiss, Germany, Czech Republic, Europe, Zurich

☆ Here are Tuesday's biggest analyst calls: Apple, Costco, Nvidia, Palantir, Broadcom, Tesla, Amazon, Meta & more
▼ + stars: | 2024-09-10 | by ( Michael Bloom | ) www.cnbc.com time to read: +5 min

"We launch coverage of GE Aerospace with an Outperform rating, target price $201." (ELF) with a Buy rating and a 12-month price target of $175 per share." "We initiate with a Buy rating on Harmony , a commercial stage biotech focused on CNS [central nervous system] disorders." "We are initiating coverage of ProKidney Corp. (PROK) with a BUY rating and $6 price target." We are initiating coverage with a BUY rating and $600 price target."

Persons: Morgan Stanley, Apple, Tesla, it's, Bernstein, Riley, Wolfe, Stryker, BUD, JMP, Redburn, BTIG, Palantir, Goldman Sachs, Nutrien, Goldman, Cantor Fitzgerald, Cantor, Melius, Johnson, Guggenheim, it's bullish, D.A, Davidson, Meta Organizations: Apple, Apple Intelligence, Intelligence, Deutsche Bank, Deutsche, GE Aerospace, GE, Inc, Anheuser, Busch InBev, Oracle, Costco, Equity, Haemonetics, Plasma Solutions, Blood Center, Hospital Care Solutions, " Bank of America, Bank of America, UBS, Amazon, Harmony Biosciences, NTR, Nvidia, Broadcom, Johnson, Johnson Controls, ProKidney Corp

☆ Stocks making the biggest moves midday: Palantir Technologies, Summit Therapeutics, JetBlue Airways and more
▼ + stars: | 2024-09-09 | by ( Sean Conlon | ) www.cnbc.com time to read: +2 min

Check out the companies making headlines in midday trading: Palantir Technologies , Dell Technologies — Palantir and Dell jumped 14% and nearly 4%, respectively, following the announcement after the bell Friday that both stocks would join the S & P 500 before the open on Sept. 23. Palantir is set to take American Airlines' spot, while Dell is going to replace Etsy. JetBlue Airways — The airline stock popped around 7% after Bank of America analyst Andrew Didora upgraded the firm to neutral from underperform. Cannabis stocks — Cannabis stocks moved higher after former President Donald Trump said in a Truth Social post that he will support legalizing adult marijuana use in Florida. A logo outside the Palantir Technologies pavilion ahead of the World Economic Forum in Davos, Switzerland, on Jan. 15, 2024.

Persons: Dell, Merck's, Andrew Didora, Didora, Arm's, Donald Trump, —, Alex Harring, Hakyung Kim, Yun Li, Jesse Pound, Michelle Fox, Stefan Wermuth Organizations: Palantir Technologies, Dell Technologies, American Airlines, Etsy, Therapeutics, Merck, JetBlue Airways —, Bank of America, JetBlue, Boeing, Citi, Federal Reserve, Arm Holdings, Financial, Apple, Monday, United States Steel, JPMorgan, Nippon Steel, Tilray Brands, Cannabis ETF, Economic, Bloomberg, Getty Locations: Florida, Davos, Switzerland

A person in Missouri has been infected with bird flu, the Centers for Disease Control and Prevention said Friday. The adult, who didn't have known contact with poultry or dairy cows, was hospitalized on Aug. 22 and has recovered. At least 196 herds of dairy cows in 14 states have confirmed outbreaks of the H5 influenza virus, according to the CDC. There has been no evidence that H5N1 — the H5 virus spreading in dairy cows — has been spreading from person to person. The Missouri State Public Health Laboratory was sent a sample from the patient, Missouri health officials said in the release.

Persons: William Schaffner, Schaffner Organizations: Centers for Disease Control, Prevention, CDC, Vanderbilt University Medical Center, Missouri State Public Health Laboratory Locations: Missouri, U.S, Nashville , Tennessee

☆ China's property woes and U.S. sanctions have hit some cities hard
▼ + stars: | 2024-09-03 | by ( Evelyn Cheng | ) www.cnbc.com time to read: +3 min

BEIJING — China's property struggles and U.S. sanctions have significantly affected some of its cities, even as others benefit from Beijing's tech push, Milken Institute's best performing cities China index showed Tuesday. Since 2015, the index has studied China's large- and mid-sized cities for their economic vibrancy and growth prospects. The index looked at a group of 33 large cities and a group of 217 small cities, then ranked them separately. Historically, Wong pointed out, having control of Zhengzhou, Hefei, and Wuhan have been critical to ensuring control of the country. Correction: This story has been updated to reflect that there are 33 large cities and 217 smaller cities in the index.

Persons: Milken Institute's, Perry Wong, Wong Organizations: CNBC ., U.S, CNBC, Wuhan Locations: HANGZHOU, CHINA, China Vanke, Hangzhou, Zhejiang province, China, BEIJING, Zhejiang, Zhuhai, Guangdong, Hong Kong, Dongguan, The, Shenzhen, Beijing, Zhengzhou, Henan province, Hefei, Wuhan, Anhui, Central China's Hubei

☆ 2 investment areas in AI that people will be 'very bullish' on in the future, according to a VC
▼ + stars: | 2024-08-26 | by ( Jaures Yip | ) www.businessinsider.com time to read: +4 min

Read previewWith the AI arms race underway and a host of industries investing in the technology, Lux Capital venture capitalist Josh Wolfe identified the areas he's particularly keen on. AI in biology"AI into biology is really interesting because most computer scientists underappreciate how hard biology is," he said. "Biology is really complex — it is not linear, it is not 'programmable biology' the way many people think." AI in roboticsWhile "robots" typically invoke images of futuristic humanoid tech like Elon Musk's Optimus, Wolfe said he thinks "humanoid robots are not going to be the way." Although Wolfe thinks humanoid robots will attract money for their intrigue, he said that robots mimicking human capabilities are "really inferior to what robots can do."

Persons: —, Josh Wolfe, Logan Bartlett, Wolfe, Meta, Nat Friedman, Daniel Gross, ESM3, Elon, Optimus Organizations: Service, Lux Capital, Business, Meta, Amazon Web Services, AWS

Harris hasn’t yet released many details about her strategy to wipe out medical debt, but policy experts say a newly implemented medical debt relief program from North Carolina could offer a roadmap. Roy Cooper announced that nearly 100 hospitals in the state had signed on to participate in the Medical Debt Relief Incentive Program, which he said will incentivize hospitals to eliminate $4 billion in medical debt for 2 million low- and middle-income patients over the next two years. At a campaign event last week in Raleigh, North Carolina, Harris thanked Cooper for canceling medical debt in his state, and Cooper introduced Harris at the convention Thursday. Hospitals will get additional federal funds if they forgive existing debt and move to prevent future medical debt. “I see medical debt as the most salient example of a health care system which isn’t working,” he said.

Persons: Kamala Harris, Harris, Harris hasn’t, Roy Cooper, Cooper, Neale Mahoney, “, ” Mahoney, ”, Adam Gaffney, Larry Levitt, Levitt, —, Mahoney, Harris ’, ” Levitt, Will, aren’t, Ciara Zachary, Zachary, it’s, Barack Obama, ” Zachary Organizations: Democratic, Convention, North Carolina Gov, Debt Relief, Stanford University, White, National Economic Council, Cambridge Health Alliance, Consumer Financial, White House, North Carolina Department of Health, Human Services, Medicaid, UNC Gillings School of Global Public Health, Medicare, Services, Republican, Affordable Locations: United States, Chicago, U.S, KFF, North Carolina, Raleigh , North Carolina, “ North Carolina, Massachusetts, —

☆ TikTok 'finfluencers' accurately called the AI rally, but credibility concerns dog them
▼ + stars: | 2024-08-16 | by ( Lim Hui Jie | ) www.cnbc.com time to read: +5 min

The team then tracked the prices of the recommended stocks from the day the videos were posted up until June 21, 2024. The most profit that an investor could have generated from a single stock would have been Nvidia, which grew 63.08% in the period surveyed. If a person invested $1,000 in every stock recommended in the one video that got the most bets right, the gains would have amounted to $4,860. On the other hand, putting money into all the stocks recommended in the video that got most bets wrong would have led to a loss of $1,517. "Furthermore, a single period coincident result does not translate to a definitive conclusion of predictability in the long run."

Persons: Dado Ruvic, Let's, —, Gerald Wong, Wong, Jeremy Tan, Jiang Zhang, — Zhang, Tan Organizations: Reuters, Nvidia, Qualcomm, Google, Ginkgo, Holdings, CNBC, Tiger Fund Management, Management, Investor Locations: York, Singapore

☆ Stocks making the biggest moves premarket: Kellanova, Alphabet, Flutter and more
▼ + stars: | 2024-08-14 | by ( Alex Harring | ) www.cnbc.com time to read: +3 min

Kellanova — Shares rose more than 6% in the premarket after the foodmaker agreed to be acquired by snackmaker Mars for $83.50 per share in cash. Flutter — The FanDuel parent popped 6.3% after posting better-than-expected revenue in the second quarter and raising its full-year guidance. Brinker International — Shares of the restaurant chain behind Chili's plunged 15% after Brinker International posted fiscal fourth-quarter earnings that disappointed and issued weaker-than-expected full-year earnings guidance. Adjusted earnings of $1.61 per share came in below the FactSet consensus estimate of $1.72 earnings per share. The Ohio-based company also raised its full-year guidance for earnings per share.

Persons: snackmaker Mars, Brinker, Chili's, Health —, Cardinal, StreetAccount, Brian Niccol, Wells Fargo, Cowen, —, Fred Imbert, Michelle Fox, Pia Singh, Sarah Min Organizations: Bloomberg News, Justice, Brinker International, Holdings —, Intel, Health, Deutsche Bank, Stifel Locations: British, Ohio, Wells

☆ Here are Wednesday's biggest analyst calls: Nvidia, Tesla, Starbucks, Chipotle, Eli Lilly, Target, TJX Companies, Coinbase and more
▼ + stars: | 2024-08-14 | by ( Michael Bloom | ) www.cnbc.com time to read: +8 min

Stifel upgrades Starbucks to buy from hold Stifel upgraded the coffee chain following the management shakeup that included a new CEO. Jefferies upgrades Sportradar to buy from hold Jefferies upgraded the Swiss global sports tech company, saying it's becoming "increasingly attractive." Morgan Stanley reiterates Target as overweight Morgan Stanley said it's sticking with its overweight rating heading into Target 's earnings next week. Berenberg reiterates Eli Lilly as buy Berenberg raised its price target on the drugmaker to $1,050 per share from $1,000. TD Cowen upgrades Ilumina to buy from hold TD Cowen sees revenue growth ahead for the biotech company.

Persons: Wolfe, PulteGroup, rais, Brian Niccol, Baird, Tesla, it's bullish, Goldman Sachs, Goldman, Elliott, Wells, Equitrans, ETRN, Jefferies, it's, SRAD, Bernstein, Chipotle, Morgan Stanley, Berenberg, Eli Lilly, Lilly, circumspection, Ross, BURL, ROST, Oppenheimer, TD Cowen, mgmt Organizations: Stifel, RBC, Johnson, underperform RBC, Elliott Management, Barclays, Nvidia, JPMorgan downgrades Emerson, JPMorgan, Deutsche Bank, Deutsche, Ball Corp, Ball Corporation, Montrose Environmental, Stock, Intuit, Citi, Palo Alto, Bank of America, TJX Companies, Argus Locations: Florida, Underperform, Swiss, Montrose, QuickBooks, Burlington, Coinbase, China, Hershey

☆ Here are Tuesday's biggest analyst calls: Netflix, Amazon, Lyft, CrowdStrike, Dell, Disney, Hormel, Eli Lilly, Home Depot & more
▼ + stars: | 2024-08-13 | by ( Michael Bloom | ) www.cnbc.com time to read: +5 min

Here are the biggest calls on Wall Street on Tuesday: Wells Fargo initiates Rollins as overweight Wells says it's bullish on shares of the pest control company. Goldman Sachs reiterates Disney as buy Goldman said it's sticking with its buy rating following Disney's biennial D23 fan event in California. " Wells Fargo initiates ITeos Therapeutics at overweight Wells said in its initiation of coverage into ITeos that the biotech company has multiple catalysts ahead. Bank of America reiterates Lyft as buy The bank said the ride sharing company is trading at a "significant discount." Wells Fargo reiterates Home Depot as overweight Wells says investors should buy the dip in Home Depot shares following earnings Tuesday morning.

Persons: Wells, Rollins, it's bullish, Goldman Sachs, Goldman, Bernstein, WBD, BTIG, Eli Lilly, Stifel, Lyft Organizations: Wells Fargo, Disney, UBS, JPMorgan, Netflix, Mizuho, Palo Alto, Barclays, Dell, DELL, Citi, Sales, Warner Brothers Discovery, ITeos, " Bank of America, Bank of America, Co, McCormick &, Depot, Amazon Locations: California, Turkey

The shots will be important, however, as the U.S. heads into the fall and winter, when cases usually rise again. Vaccine experts select the Covid strain in the spring for a vaccination campaign in the fall. Last fall, when CDC data showed a rise in hospitalizations, some doctors criticized the FDA for waiting too long to roll out the updated Covid vaccines. Has the FDA considered changing the fall vaccine rollout schedule, now early September? Link-Gelles highlighted the challenges in determining the optimal timing for administering the Covid vaccines.

Persons: Will, ”, John Moore, Akiko Iwasaki, Covid —, CDC epidemiologist Ruth Link, that’s, Isaac Bogoch, “, Ofer Levy, Levy, ” Levy, it’s, ” Weill Cornell's Moore, “ I’m, what’s, ” Moore Organizations: Weill Cornell Medical College, “, Centers for Disease Control, Food and Drug Administration, Yale University, FDA, CDC, NBC, University of Toronto, Precision, Boston Children’s Hospital Locations: U.S, hospitalizations

☆ Morgan Stanley just added these 3 safe stocks to their 'buy' list with the market expected to stay choppy
▼ + stars: | 2024-08-12 | by ( Filip De Mott | ) www.businessinsider.com time to read: +4 min

Morgan Stanley has added three new high-quality defensive stocks to its "Fresh Money Buy List." AdvertisementMorgan Stanley expanded its list of recommended equities with three high-quality stocks, as the bank veer further into defensive positioning. These names could help shield against ongoing macro uncertainty, which Morgan Stanley does not expect will resolve anytime soon. Morgan Stanley holds an Overweight rating on the company, with a price target of $211 per share. (3) Northrop GrummanNOC, the defense and aerospace company, joined Morgan Stanley's list as a premium equity for exposure to industrials.

Persons: Morgan Stanley, —, Consumer Staples, Wilson, Public Service Enterprise Group Morgan Stanley, Morgan Stanley's Organizations: Service, Federal, Healthcare, Consumer, Public Service Enterprise Group, Northrop Grumman NOC, Verizon, Walmart Locations: Real

☆ Biotech stocks will get a tailwind from rate cuts, says Stempoint's Michelle Ross
▼ + stars: | 2024-08-12 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBiotech stocks will get a tailwind from rate cuts, says Stempoint's Michelle RossMichelle Ross, Stempoint Capital, joins 'Closing Bell' to discuss Eli Lilly after the stock saw a slight dip after rallying.

Persons: Stempoint's Michelle Ross Michelle Ross, Eli Lilly Organizations: Biotech Locations: Stempoint

☆ I.V.F. Threats in Alabama Drive Clinics to Ship Out Embryos
▼ + stars: | 2024-08-12 | by ( Azeen Ghorayshi | Sarah Kliff | ) www.nytimes.com time to read: +1 min

An emerging movement against in vitro fertilization is driving some doctors and patients in red states to move or destroy frozen embryos. The embryo migration is most striking in Alabama, where the State Supreme Court ruled in February that embryos were “unborn children.” Since then, at least four of Alabama’s seven fertility clinics have hired biotech companies to move the cells elsewhere. A fifth clinic is working with a doctor in New York to discard embryos because of concerns about the legality of doing so in Alabama. Since the Supreme Court’s 2022 decision to overturn Roe v. Wade, 14 states have passed total or near total abortion bans. And the Southern Baptists, the country’s largest Protestant denomination, voted in June to oppose I.V.F., calling for the protection of “frozen embryonic human beings.”

Persons: Roe, Wade Organizations: Baptists, I.V.F Locations: Alabama, New York

Search resuls for: "biotech"

25 mentions found